A Double-Blind, Placebo-Controlled, Comparative Study of KES524 in Patients With Obesity Disease.

Trial Profile

A Double-Blind, Placebo-Controlled, Comparative Study of KES524 in Patients With Obesity Disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Sibutramine (Primary)
  • Indications Obesity
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 May 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
    • 29 Nov 2007 Results reported in an Eisai media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top